OrthoPediatrics Corp. has provided Preliminary unaudited earnings guidance for the fourth quarter and full year ended December 31, 2018. The company expects revenue to be in the range of $14.5 million to $14.7 million, up 24% to 26%, when compared to $11.7 million in the fourth quarter of 2017. For the full year, the company expects revenue to be in the range of $57.5 million to $57.7 million, representing annual growth of 26%.